230 related articles for article (PubMed ID: 30924452)
1. Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms.
Huang YH; Zhang YQ; Huang JT
Asian J Androl; 2019; 21(3):291-295. PubMed ID: 30924452
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Kaur H; Samarska I; Lu J; Faisal F; Maughan BL; Murali S; Asrani K; Alshalalfa M; Antonarakis ES; Epstein JI; Joshu CE; Schaeffer EM; Mosquera JM; Lotan TL
Prostate; 2020 Sep; 80(12):1012-1023. PubMed ID: 32649013
[TBL] [Abstract][Full Text] [Related]
3. PC3 is a cell line characteristic of prostatic small cell carcinoma.
Tai S; Sun Y; Squires JM; Zhang H; Oh WK; Liang CZ; Huang J
Prostate; 2011 Nov; 71(15):1668-79. PubMed ID: 21432867
[TBL] [Abstract][Full Text] [Related]
4. Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.
Heaphy CM; Haffner MC; Graham MK; Lim D; Davis C; Corey E; Epstein JI; Eisenberger MA; Wang H; De Marzo AM; Meeker AK; Lotan TL
Hum Pathol; 2020 Jul; 101():70-79. PubMed ID: 32389660
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.
Chen H; Sun Y; Wu C; Magyar CE; Li X; Cheng L; Yao JL; Shen S; Osunkoya AO; Liang C; Huang J
Endocr Relat Cancer; 2012 Jun; 19(3):321-31. PubMed ID: 22389383
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.
Butler W; Huang J
Precis Clin Med; 2021 Mar; 4(1):25-34. PubMed ID: 33842835
[TBL] [Abstract][Full Text] [Related]
7. Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
Butler W; Xu L; Zhou Y; Cheng Q; Hauck JS; He Y; Marek R; Hartman Z; Cheng L; Yang Q; Wang ME; Chen M; Zhang H; Armstrong AJ; Huang J
J Pathol; 2023 May; 260(1):43-55. PubMed ID: 36752189
[TBL] [Abstract][Full Text] [Related]
8. p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.
Li Z; Sun Y; Chen X; Squires J; Nowroozizadeh B; Liang C; Huang J
Mol Cancer Res; 2015 Mar; 13(3):584-91. PubMed ID: 25512615
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
[TBL] [Abstract][Full Text] [Related]
10. Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.
Lipianskaya J; Cohen A; Chen CJ; Hsia E; Squires J; Li Z; Zhang Y; Li W; Chen X; Xu H; Huang J
Asian J Androl; 2014; 16(4):541-4. PubMed ID: 24589459
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H; Rickman DS; Park K; Chae SS; Sboner A; MacDonald TY; Wang Y; Sheikh KL; Terry S; Tagawa ST; Dhir R; Nelson JB; de la Taille A; Allory Y; Gerstein MB; Perner S; Pienta KJ; Chinnaiyan AM; Wang Y; Collins CC; Gleave ME; Demichelis F; Nanus DM; Rubin MA
Cancer Discov; 2011 Nov; 1(6):487-95. PubMed ID: 22389870
[TBL] [Abstract][Full Text] [Related]
12. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.
Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N
Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967
[TBL] [Abstract][Full Text] [Related]
13. GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression.
Solorzano SR; Imaz-Rosshandler I; Camacho-Arroyo I; García-Tobilla P; Morales-Montor G; Salazar P; Arena-Ortiz ML; Rodríguez-Dorantes M
Sci Rep; 2018 Jul; 8(1):10272. PubMed ID: 29980692
[TBL] [Abstract][Full Text] [Related]
14. [Role of neuroendocrine cells in prostate cancer progression].
Sciarra A; Innocenzi M; Ravaziol M; Minisola F; Alfarone A; Cattarino S; Panebianco V; Buonocore V; Gentile V; Di Silverio F
Urologia; 2011; 78(2):126-31. PubMed ID: 21574145
[TBL] [Abstract][Full Text] [Related]
15. Molecular model for neuroendocrine prostate cancer progression.
Chen R; Dong X; Gleave M
BJU Int; 2018 Oct; 122(4):560-570. PubMed ID: 29569310
[TBL] [Abstract][Full Text] [Related]
16. Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
Moritz T; Venz S; Junker H; Kreuz S; Walther R; Zimmermann U
Tumour Biol; 2016 Aug; 37(8):10435-46. PubMed ID: 26846108
[TBL] [Abstract][Full Text] [Related]
17. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine differentiation in prostate cancer].
Wu CY; Na YQ; Yao JL; di Sant'Agnese PA; Huang JT
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):565-7. PubMed ID: 17134555
[No Abstract] [Full Text] [Related]
19. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma.
Sagnak L; Topaloglu H; Ozok U; Ersoy H
Clin Genitourin Cancer; 2011 Dec; 9(2):73-80. PubMed ID: 22035833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
